Doctor profile · Federal record
Dr. TANVISHA MODY, MD
Endocrinology, Diabetes & Metabolism Physician (CMS: ENDOCRINOLOGY) · NEW HYDE PARK, NY
- NPI 1124475751
- Accepts Medicare
- MIPS 75.0 / 100 · 2023
- 11 yrs in practice
- Female
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
2 OHIO DR STE 201
NEW HYDE PARK, NY 110421111
(516) 390-5760
fax (516) 390-5765
Credentials & registration
- NPI registered
- May 2016 — 10 yrs on file
- Profile last updated
- February 2, 2024
- Year of graduation
- 2015 — 11 yrs since
- Specialty taxonomy
- 207RE0101X — NUCC code
- State license (1)
- New York #322629
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1124475751. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
2,805
Distinct HCPCS
10
Medicare allowed
$171,849
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J0897 |
Injection, denosumab, 1 mg | 1,020 | 13 | $23 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 610 | 323 | $126 | |
83036 |
Hemoglobin a1c level | 225 | 167 | $9 | |
95251 |
Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | 199 | 104 | $34 | |
99204 |
New patient office or other outpatient visit, 45-59 minutes | 157 | 157 | $179 | |
99490 |
Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | 103 | 47 | $62 | |
G0108 |
Diabetes outpatient self-management training services, individual, per 30 minutes | 95 | 31 | $54 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 85 | 67 | $89 | |
G0109 |
Diabetes outpatient self-management training services, group session (2 or more), per 30 minutes | 85 | 15 | $15 | |
96372 |
Injection of drug or substance under skin or into muscle | 54 | 17 | $14 |
In context: peer comparison
Among 9 peers in this city , average services per provider: 976. This provider delivers 2.9× the peer median.Open Payments
Industry payments received
All-time total
$20
Transactions
1
Manufacturers
1
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| ABBVIE INC. | 1 | $20.23 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
1,370
Patients
514
Total drug cost
$914,502
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Levothyroxine Sodium | Generic | 180 | 69 | $2,856 |
| Ozempic (Semaglutide) | Brand | 169 | 62 | $279,044 |
| Soliqua 100-33 (Insulin Glargine/Lixisenatide) | Brand | 124 | 46 | $165,981 |
| Metformin Hcl Er (Metformin Hcl) | Brand | 118 | 48 | $2,017 |
| Metformin Hcl | Generic | 113 | 38 | $969 |
| Synthroid (Levothyroxine Sodium) | Brand | 95 | 31 | $11,010 |
| Glimepiride | Generic | 87 | 37 | $1,745 |
| Trulicity (Dulaglutide) | Brand | 85 | 31 | $146,527 |
| Glipizide Er (Glipizide) | Brand | 70 | 21 | $3,243 |
| Lantus Solostar (Insulin Glargine,hum.Rec.Anlog) | Brand | 68 | 30 | $39,947 |